Company Disclosures
11 November 2024
Notification of the resolution of the Board of Directors Meeting No.8/2024 (the Condensed interim financial statements for the three-month and nine-month periods ended 30 September 2024) and the refusal to exercise the right under ROFO/ROFR Agreement
11 November 2024
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024
11 November 2024
Financial Performance Quarter 3 (F45) (Reviewed)
14 August 2024
Notification of the resolution of the Board of Directors Meeting No.6/2024 (the Condensed interim financial statements for the three-month and six-month periods ended 30 June 2024)
14 August 2024
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
14 August 2024
Financial Performance Quarter 2 (F45) (Reviewed)
31 July 2024
Report of the utilization of increased capital from initial public offering (IPO)
12 July 2024
Notification of the investment which results in the acquisition of a subsidiary company
14 May 2024
Notification of the resolution of the Board of Directors Meeting No.4/2024 (the Condensed interim financial statements for the three-month period ended 31 March 2024)
14 May 2024
Financial Performance Quarter 1 (F45) (Reviewed) (Revised)
14 May 2024
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
14 May 2024